Cytosorbents (CTSO) Misses Q1 EPS by 1c

Cytosorbents (NASDAQ: CTSO) reported Q1 EPS of ($0.05), $0.01 worse than the analyst estimate of ($0.04). Revenue for the quarter came in at $8.9 million versus the consensus estimate of $9.23 million.

For earnings history and earnings-related data on Cytosorbents (CTSO) click here.

You May Also Be Interested In

• HighPeak Energy mulls sale - Reuters
• Goldman sees India AI infrastructure stocks up 60% in 2026
• FAA officials are preparing to launch an AI-powered air-traffic tool in one of the nation’s busiest corridors as soon as Monday - WSJ